lambda
interferon
ifnl
type
iii
ifn
describ
fifteen
year
ago
novel
cytokin
share
structur
function
homolog
type
ifn
respect
ifnl
engag
uniqu
receptor
complex
compris
nevertheless
share
signal
cascad
mani
function
type
ifn
question
possibl
nonredund
role
overal
biolog
import
review
latest
evid
establish
primaci
ifnl
front
line
protect
anatom
barrier
mediat
antivir
immun
type
ifn
also
discuss
emerg
role
regul
inflamm
limit
host
damag
major
differ
type
ifn
ifnl
come
thu
light
dual
function
cytokin
mediat
antivir
immun
damag
control
lambda
interferon
come
light
dual
function
cytokin
mediat
antivir
immun
damag
control
evangelo
andreako
ivan
zanoni
ioanna
e
galani
lambda
interferon
ifnl
type
iii
ifn
describ
fifteen
year
ago
novel
cytokin
share
structur
function
homolog
type
ifn
respect
ifnl
engag
uniqu
receptor
complex
compris
nevertheless
share
signal
cascad
mani
function
type
ifn
question
possibl
nonredund
role
overal
biolog
import
review
latest
evid
establish
primaci
ifnl
front
line
protect
anatom
barrier
mediat
antivir
immun
type
ifn
also
discuss
emerg
role
regul
inflamm
limit
host
damag
major
differ
type
ifn
ifnl
come
thu
light
dual
function
cytokin
mediat
antivir
immun
damag
control
long
time
type
interferon
ifn
consid
primari
antivir
defens
system
act
autocrin
paracrin
manner
induc
resist
infect
enhanc
innat
adapt
immun
respons
need
viral
clearanc
moreov
attract
major
interest
oncolog
multipl
sclerosi
biolog
respons
modifi
abl
improv
therapi
howev
although
type
ifn
approv
divers
indic
includ
genit
wart
viral
hepat
hairi
cell
leukemia
chronic
myelogen
leukemia
use
clinic
limit
due
frequent
sever
advers
effect
includ
flulik
diseas
depress
exhibit
complet
human
genom
project
becam
appar
anoth
cytokin
famili
term
lambda
ifn
ifnl
type
iii
ifn
exist
share
structur
homolog
interleukin
il
famili
function
homolog
type
ifn
similarli
type
ifn
ifnl
trigger
infect
induc
multipl
antivir
respons
mediat
viral
clearanc
also
exert
pleiotrop
effect
immun
system
mani
highli
reminisc
type
ifn
rais
question
whether
ifnl
type
ifn
redund
organ
need
two
ifnbas
antivir
defens
system
confront
infect
review
latest
evid
highlight
primaci
ifnl
antimicrobi
particular
antivir
immun
survey
uniqu
common
biolog
type
ifn
cooper
type
ifn
finetun
antimicrobi
immun
emerg
role
damag
control
also
discuss
potenti
novel
therapeut
exhibit
benefici
effect
lack
proinflammatori
activ
caus
side
effect
type
ifn
four
ifnl
member
human
two
mice
much
like
type
ifn
ifnl
transient
express
follow
stimul
virus
microbi
product
includ
major
respiratori
influenza
parainfluenza
virus
rhinovirus
respiratori
syncyti
virus
coronavirus
etc
gastrointestin
rotavirus
reovirus
norovirus
hepatotrop
hepat
b
c
virus
intracellular
extracellular
bacteria
listeria
monocytogen
streptococcu
pneumonia
haemophilu
influenza
staphylococcu
aureu
salmonella
enterica
shigella
sonnei
mycobacterium
tuberculosi
numer
microbi
compon
synthet
ligand
imidazoquinolin
polyinosinicpolycytidyl
acid
flagellin
peptidoglycan
cpg
oligodeoxynucleotid
central
ifnl
product
patternrecognit
receptor
prr
tolllik
receptor
tlr
rigi
trigger
downstream
signal
cascad
lead
activ
nuclear
factor
kb
nfkb
interferon
regulatori
factor
irf
accordingli
ifnl
gene
bind
site
nfkb
promot
region
similarli
type
ifn
although
would
suggest
coregul
often
case
ifnl
exhibit
restrict
pattern
express
compar
type
ifn
almost
ubiquit
express
ifnl
abund
barrier
surfac
includ
respiratori
gastrointestin
tract
robustli
produc
epithelia
epithelialorigin
cell
includ
hepatocyt
immun
cell
goe
beyond
abil
cell
respond
prr
engag
suggest
exist
addit
cellspecif
epigenet
transcript
posttranscript
regul
ifnl
product
exampl
rigilik
receptor
signal
mitochondri
antivir
signal
protein
mav
peroxisom
sens
cytosol
dna
sensor
induct
transcript
coactiv
presenc
transcript
repressor
associ
ifnl
product
whether
mechan
broadli
account
ifnl
express
pattern
remain
establish
ifnl
member
engag
uniqu
heterodimer
receptor
complex
ifnlr
compris
ifnlra
confer
ligand
specif
enabl
receptor
assembl
share
famili
member
requir
signal
bind
ifnl
occur
stoichiometri
compar
ratio
ifnlr
stimul
lead
activ
tyrosin
kinas
transcript
factor
bind
form
ifnstimul
gene
factor
complex
enter
nucleu
induc
transcript
hundr
gene
term
ifnstimul
gene
isg
gener
inhibit
viral
replic
spread
exhibit
broad
antimicrobi
function
viral
bacteri
parasit
infect
notabl
pathway
also
share
type
ifn
highlight
similar
antivir
activ
two
system
exhibit
thu
difficult
segreg
ifnl
type
ifn
function
transcript
respons
ifnlinduc
gene
typic
repres
subset
gene
elicit
type
ifn
exhibit
delay
peak
longer
durat
strike
differ
two
ifn
system
receptor
distribut
type
ifn
receptor
express
almost
cell
type
contrari
complex
express
primarili
cell
epitheli
origin
immun
cell
mainli
neutrophil
subset
dendrit
cell
dc
confer
select
ifnl
respons
demonstr
mous
human
neutrophil
plasmacytoid
dc
pdc
well
human
monocytederiv
dc
mous
bone
marrowderiv
lungsort
convent
dc
cdc
phenotyp
figur
express
pattern
receptor
larg
follow
ligand
human
mous
epitheli
cell
pdc
cell
well
human
monocytederiv
dc
macrophag
express
high
level
ifnl
upon
activ
point
special
role
ifnl
local
immun
respons
epitheli
barrier
surfac
confer
epitheli
immun
cell
howev
subtler
differ
also
exist
exampl
phosphoryl
induc
ifnl
type
ifn
less
welldescrib
pathway
may
also
import
antivir
function
indic
exist
distinct
signal
event
remain
character
first
public
describ
discoveri
ifnl
becam
evid
ifnl
exhibit
potent
antivir
activ
treatment
infect
cell
cultur
experiment
anim
recombin
ifnl
effect
divers
rang
virus
howev
endogen
nonredund
role
ifnl
compens
type
ifn
difficult
establish
import
progress
recent
come
studi
gastrointestin
infect
shown
cell
respons
ifnl
larg
compartment
ifnl
act
intestin
epitheli
cell
express
high
level
minim
effect
lamina
propria
cell
express
low
level
type
ifn
exhibit
opposit
effect
accordingli
demonstr
rotaviruswhich
infect
epitheli
cell
sole
control
ifnl
reoviru
replic
epitheli
nonepitheli
cell
spread
systemicallyrequir
cooper
action
ifnl
type
ifn
similarli
noroviru
grow
gastrointestin
epithelium
spread
system
confront
ifn
system
interestingli
ifnl
effect
clear
noroviru
antibioticstr
mice
effect
prohibit
gut
commens
ad
anoth
level
complex
equat
respiratori
tract
compartment
less
obviou
respiratori
epitheli
cell
express
receptor
respond
type
ifn
certain
immun
cell
popul
resid
infiltr
lung
moreov
although
nose
bronchial
alveolar
epitheli
cell
express
high
level
ifnl
follow
infect
smooth
muscl
cell
fibroblast
dc
also
suggest
degre
redund
two
ifn
system
support
earli
work
show
increas
suscept
respiratori
viral
infect
mice
defici
mice
defici
howev
recent
studi
uncov
major
uniqu
role
ifnl
antivir
immun
lung
reveal
ifnl
induc
first
lower
viral
burden
type
ifn
act
limit
initi
infect
spread
possibl
due
propens
airway
epitheli
cell
select
produc
type
iii
ifn
line
report
ifnl
essenti
prevent
viru
transmiss
upper
airway
lung
process
take
place
earli
infect
interestingli
ifnl
lack
strong
proinflammatori
effect
type
ifn
rather
antiinflammatori
tissu
protect
result
mice
exhibit
increas
viral
load
inflamm
host
damag
follow
infect
wherea
recombin
treatment
potent
suppress
outcom
also
case
mice
treat
neutral
antibodi
data
support
model
ifnl
confer
initi
antivir
protect
without
provok
unnecessari
inflamm
type
ifn
come
play
second
line
defens
enhanc
antivir
respons
expens
collater
damag
figur
model
ifnl
action
consist
behavior
ifnl
gastrointestin
tract
may
therefor
explain
broader
role
antivir
defens
inde
liver
ifnl
also
import
provid
protect
immun
hbc
hcv
infect
demonstr
mani
ifnl
gene
polymorph
link
improv
spontan
treatmentinduc
viral
clearanc
effect
ifnl
therapi
interestingli
attribut
abil
human
hepatocyt
preferenti
gener
respond
ifnl
similarli
respiratori
epitheli
cell
moreov
skin
ifnl
predominantli
express
type
ifn
associ
reduc
incid
infect
addit
virus
bacteri
fungal
infect
also
trigger
ifnl
product
l
monocytogen
enterica
sonnei
well
sever
bacteri
ligand
induc
ifnl
mainli
manner
function
import
vitro
ifnl
enhanc
epitheli
barrier
integr
prevent
bacteri
dissemin
vivo
model
aureu
pseudomona
aeruginosa
infect
mice
exhibit
lower
lambda
interferon
antivir
immun
damag
control
andreako
zanoni
galani
bacteri
load
less
patholog
although
inflammatori
cell
infiltr
affect
also
intranas
infect
mice
aureu
led
significantli
increas
bacteri
clearanc
time
decreas
proinflammatori
cytokin
includ
airway
interestingli
studi
product
appear
regul
proteas
releas
neutrophil
rather
activ
moreov
model
invas
aspergillosi
aspergillu
fumigatu
mice
develop
aggrav
diseas
higher
fungal
load
lung
sever
fungal
invas
larg
due
ifnlmedi
activ
neutrophil
shown
protect
host
studi
therefor
need
shed
light
wider
role
ifnl
antimicrobi
defens
beyond
viral
infect
sharp
contrast
type
ifn
ifnl
receptor
ubiquit
express
immun
system
rather
ifnl
produc
pdc
cdc
monocytederiv
dc
macrophag
earlier
discuss
function
neutrophil
pdc
monocytederiv
dc
cell
leukocyt
ifnl
therefor
signal
restrict
set
leukocyt
exert
select
immun
modulatori
function
start
becom
understood
primari
emerg
activ
ifnl
regul
innat
immun
contrari
type
ifn
ifnl
suppress
innat
proinflammatori
respons
limit
host
damag
effect
associ
inflamm
larg
due
select
action
neutrophil
prevent
proinflammatori
activ
function
thu
context
influenza
viral
infect
ifnl
restrain
product
tnf
tissu
destruct
mediat
neutrophil
allow
effect
antivir
respons
develop
although
unclear
whether
direct
effect
nevertheless
show
ifnl
critic
involv
keep
inflamm
control
limit
collater
damag
context
chronic
intestin
inflamm
ifnl
act
directli
neutrophil
inhibit
gener
ro
degranul
process
mediat
ifnl
also
induc
addit
benefici
effect
acceler
mucos
heal
exogen
administr
recombin
ifnl
experiment
anim
model
influenza
viru
infect
coliti
confirm
regulatori
antiinflammatori
activ
highlight
therapeut
potenti
moreov
exogen
administr
recombin
ifnl
shown
therapeut
potenti
diseas
ifnl
may
produc
natur
collageninduc
model
ifnl
action
ifnl
confer
initi
antivir
protect
anatom
barrier
without
provok
unnecessari
inflamm
type
ifn
come
second
line
defens
follow
escap
ifnl
control
enhanc
antivir
immunoinflammatori
respons
expens
though
collater
damag
arthriti
efficaci
ifnl
treatment
attribut
inhibitori
effect
ifnl
neutrophil
migrat
arteri
thrombosi
ifnlmedi
protect
due
suppress
effect
ifnl
neutrophilextracellular
trap
net
format
antiinflammatori
immunemodulatori
behavior
ifnl
reminisc
activ
ifnl
share
sequenc
homolog
subunit
signal
figur
anoth
major
activ
ifnl
regul
adapt
immun
ifnl
signal
cell
pdc
human
mous
origin
modul
function
vitro
ifnl
enhanc
propens
human
monocytederiv
dc
gener
regulatori
cell
vivo
ifnl
suppress
abil
mous
cell
induc
helper
differenti
enhanc
cell
develop
consist
cell
cultur
studi
use
mous
cell
human
peripher
blood
mononuclear
cell
pbmc
interestingli
snp
locu
link
higher
product
skew
follow
pbmc
stimul
influenza
viru
shift
ifng
product
nk
cell
also
observ
might
indirect
neither
nk
cell
cell
seem
respond
ifnl
skew
effect
ifnl
may
relat
capac
increas
express
polar
cytokin
contextdepend
manner
noteworthi
cytotox
cell
respons
may
also
affect
ifnl
increas
cell
respons
report
mice
follow
acut
lcmv
infect
interestingli
celldriven
diseas
experiment
anim
ifnl
therapeut
effect
allerg
asthma
ifnl
potent
suppress
activ
respons
develop
immunopatholog
autoimmun
arthriti
also
inhibit
induct
gd
cell
respons
amelior
diseas
ifnl
therefor
appear
broadli
protect
acut
chronic
inflammatori
diseas
mediat
immun
modulatori
action
aim
restor
immunolog
balanc
limit
direct
tissu
damag
caus
byproduct
host
defens
figur
last
year
ifnl
come
shadow
type
ifn
emerg
front
line
defens
system
mediat
antivir
immun
anatom
barrier
gastrointestin
respiratori
tract
also
emerg
novel
immun
regulatori
cytokin
special
duti
damag
control
act
maintain
immunolog
balanc
limit
immunopatholog
extend
beyond
infect
ifnl
limit
inflamm
prevent
host
damag
divers
diseas
includ
coliti
autoimmun
arthriti
allerg
asthma
central
uniqu
biolog
ifnl
select
action
neutrophil
prevent
proinflammatori
activ
inhibit
ro
product
degranul
net
format
regul
migratori
capac
sharp
contrast
proinflammatori
effect
type
ifn
instead
activ
neutrophil
leukocyt
highlight
properti
ifnl
remain
investig
lambda
interferon
antivir
immun
damag
control
andreako
zanoni
galani
may
also
explain
improv
safeti
profil
ifnl
exhibit
clinic
dual
antimicrobi
immun
regulatori
function
ifnl
make
particularli
attract
treatment
infecti
diseas
chronic
disord
asthma
coliti
infect
exacerb
sever
ifnl
select
regul
antivir
respons
limit
host
damag
inflamm
symptom
also
advoc
broader
evalu
ifnl
finetun
immun
diseas
involv
neutrophil
inflamm
alter
balanc
studi
toward
direct
therefor
eagerli
await
ifnl
dual
function
cytokin
mediat
antivir
activ
damag
control
schemat
show
uniqu
nonredund
role
ifnl
antivir
defens
immun
regulatori
action
mediat
diseas
protect
emerg
last
year
e
andreako
receiv
consult
fee
vorso
corp
thought
research
grant
novosom
ag
janssen
zanoni
galani
declar
relev
conflict
interest
influenza
viru
infect
without
compromis
host
fit
immun
studi
reveal
nonredund
role
ifnl
frontlin
antivir
protect
respiratori
tract
demonstr
ifnl
mediat
initi
antivir
defens
type
ifn
without
provok
unnecessari
inflamm
caus
damag
also
uncov
import
ifn
system
finetun
neutrophil
function
antivir
immun
